SAN DIEGO, Oct. 24, 2019 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), is pleased to announce clinical study support for Horizon Therapeutics plc (Nasdaq: HZNP) to measure methotrexate polyglutamates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback